While Ozempic was initially approved to help manage type 2 diabetes by regulating blood sugar, both Ozempic (off-label) and Wegovy have demonstrated significant weight loss benefits in clinical studieseven for individuals who do not have diabetes
Significant weight loss from tirzepatide may reduce levothyroxine requirements in some patients, necessitating TSH monitoring at baseline, after substantial weight loss, and every 6-12 months once stable
These might be to blame for your lower abdominal pain
Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, metabolic factors, consistency of use, adherence to lifestyle modifications, genetic factors, current medications, and other individual variables